BIB
$55.87
ProShares Ultra Nasdaq Biotechnology
Fund Family: ProShares Trust
1 Month
+8.83%
YTD
-15.62%
1 Year
-15.62%
3 Year
+11.08%
Top 10 Holdings (49.3% of portfolio)
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | United States of America | B | Manufacturing | 10.14% |
| 2 | Gilead Sciences Inc | GILD | Manufacturing | 6.41% |
| 3 | Amgen Inc | AMGN | Manufacturing | 6.23% |
| 4 | Vertex Pharmaceuticals Inc | VRTX | Manufacturing | 6.13% |
| 5 | MOTION FINCO SARL | 000000000 | Manufacturing | 4.50% |
| 6 | Regeneron Pharmaceuticals Inc | REGN | Manufacturing | 4.38% |
| 7 | AstraZeneca PLC | AZN | Manufacturing | 3.52% |
| 8 | Alnylam Pharmaceuticals Inc | ALNY | Manufacturing | 3.27% |
| 9 | Invesco Government & Agency Portfolio | AGPXX | Unknown | 3.12% |
| 10 | Biogen Inc | BIIB | Manufacturing | 1.58% |
Fund Information
| Net Assets | $44.30M | Expense Ratio | N/A |
| Total Holdings | 265 | Annual Fee* | N/A |
| Inception Date | N/A | Fund Family | ProShares Trust |
*Annual fee per $10,000 invested